PETER N. KELLOGG - 07 Mar 2023 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: /s/ Andrew Mayer, Attorney-in-Fact For: Peter N. Kellogg
Issuer symbol
ALNY
Transactions as of
07 Mar 2023
Net transactions value
$0
Form type
4
Filing time
09 Mar 2023, 15:12:06 UTC
Next filing
20 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Award $0 +4,948 $0.000000 4,948 07 Mar 2023 Common Stock 4,948 $194.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant.